Cytomx Therapeutics, Inc.
CTMX
Revenue
5.96M
▼-12.70M▼-68.04%
3 Months ChangeAssets
158.25M
▼-16.80M▼-9.60%
3 Months ChangeLiabilities
50.87M
▼-4.28M▼-7.76%
3 Months ChangeFree Cash Flow
-21.16M
▲5.00M▲19.11%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2025-11-06
Form 8-K
ID: 0001193125-25-269533
2025-11-06
Form 10-Q
ID: 0001193125-25-269477
2025-08-13
Form 8-K
ID: 0001193125-25-179463
2025-08-07
Form 8-K
ID: 0000950170-25-105053
2025-08-07
Form 10-Q
ID: 0000950170-25-104991
2025-06-13
Form 8-K
ID: 0001193125-25-140739
2025-05-28
Form 8-K
ID: 0001193125-25-129470
2025-05-13
Form 8-K
ID: 0001193125-25-118805
2025-05-12
Form 8-K
ID: 0001193125-25-117245
2025-05-12
Form 10-Q
ID: 0000950170-25-068511